FTC Urges Court Not To Nix AbbVie Pay-For-Delay Suit
The U.S. Federal Trade Commission on Monday urged a Pennsylvania federal court to keep alive its pay-for-delay lawsuit accusing AbbVie Inc. of keeping Teva Pharmaceuticals USA Inc.'s generic AndroGel off the...To view the full article, register now.
Already a subscriber? Click here to view full article